Journal of Clinical Medicine (May 2021)

Is Skeletal Muscle Dysfunction a Limiting Factor of Exercise Functional Capacity in Patients with Sickle Cell Disease?

  • Etienne Gouraud,
  • Philippe Connes,
  • Alexandra Gauthier-Vasserot,
  • Camille Faes,
  • Salima Merazga,
  • Solène Poutrel,
  • Céline Renoux,
  • Camille Boisson,
  • Philippe Joly,
  • Yves Bertrand,
  • Arnaud Hot,
  • Giovanna Cannas,
  • Christophe Hautier

DOI
https://doi.org/10.3390/jcm10112250
Journal volume & issue
Vol. 10, no. 11
p. 2250

Abstract

Read online

Patients with sickle cell disease (SCD) have reduced functional capacity due to anemia and cardio–respiratory abnormalities. Recent studies also suggest the presence of muscle dysfunction. However, the interaction between exercise capacity and muscle function is currently unknown in SCD. The aim of this study was to explore how muscle dysfunction may explain the reduced functional capacity. Nineteen African healthy subjects (AA), and 24 sickle cell anemia (SS) and 18 sickle cell hemoglobin C (SC) patients were recruited. Maximal isometric torque (Tmax) was measured before and after a self-paced 6-min walk test (6-MWT). Electromyographic activity of the Vastus Lateralis was recorded. The 6-MWT distance was reduced in SS (p p < 0.01) patients compared to AA subjects. However, Tmax and root mean square value were not modified by the 6-MWT, showing no skeletal muscle fatigue in all groups. In a multiple linear regression model, genotype, step frequency and hematocrit were independent predictors of the 6-MWT distance in SCD patients. Our results suggest that the 6-MWT performance might be primarily explained by anemia and the self-paced step frequency in SCD patients attempting to limit metabolic cost and fatigue, which could explain the absence of muscle fatigue.

Keywords